Literature DB >> 20554462

Expression of urocortin peptides in canine myocardium and plasma.

Gemma Fraga Veloso1, Dan G Ohad, Andrew J Francis, Joan M Vaughan, David G Brownstein, Geoffrey J Culshaw, Wylie W Vale, Anne T French, Pauline M Jamieson.   

Abstract

Urocortin (Ucn) peptides are the endogenous ligands for the corticotropin-releasing factor type 2 receptor (CRFR2). They have potentially important roles in cardiovascular physiology in health and disease, and show promise as therapeutics for congestive heart failure. Analysis of canine heart tissue showed mRNA expression of Ucn 1, Ucn 3 and CRFR2 in all heart chambers. Immunohistochemistry also demonstrated Ucns 1 and 3 expression in cardiomyocytes. To assess the potential usefulness of circulating Ucns as markers of heart disease, plasma samples from 45 dogs with cardiac disease and 15 controls were analysed by radioimmunoassay. Both Ucns 1 and 3 were measurable but the presence of cardiac disease did not alter their concentrations. Therefore, whilst Ucns are expressed in canine myocardium (where they may play a role in the endogenous neurohumoral response to cardiac disease or failure) they do not appear to be sensitive biomarkers of cardiac disease in our canine patient population.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554462      PMCID: PMC2982926          DOI: 10.1016/j.tvjl.2010.05.019

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  33 in total

1.  The localisation of urocortin in the adult rat cerebellum: a light and electron microscopic study.

Authors:  J D Swinny; D Kalicharan; A Gramsbergen; J J L van der Want
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.

Authors:  S Y Hsu; A J Hsueh
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.

Authors:  Yuichiro Kimura; Kazuhiro Takahashi; Kazuhito Totsune; Yasunari Muramatsu; Chika Kaneko; Andrew D Darnel; Takashi Suzuki; Masahito Ebina; Toshihiro Nukiwa; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Distribution of urocortin-like immunoreactivity in the central nervous system of the frog Rana esculenta.

Authors:  Tamás Kozicz; Akira Arimura; Jerome L Maderdrut; Gyula Lázár
Journal:  J Comp Neurol       Date:  2002-11-11       Impact factor: 3.215

7.  mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues.

Authors:  S M Baigent; P J Lowry
Journal:  J Mol Endocrinol       Date:  2000-08       Impact factor: 5.098

8.  Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

Authors:  Bhawanjit K Brar; Anne K Jonassen; Elena M Egorina; Alon Chen; Alejandra Negro; Marilyn H Perrin; Ole D Mjøs; David S Latchman; Kuo-Fen Lee; Wylie Vale
Journal:  Endocrinology       Date:  2003-09-11       Impact factor: 4.736

9.  Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion.

Authors:  Chien Li; Peilin Chen; Joan Vaughan; Amy Blount; Alon Chen; Pauline M Jamieson; Jean Rivier; M Susan Smith; Wylie Vale
Journal:  Endocrinology       Date:  2003-07       Impact factor: 4.736

10.  Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells.

Authors:  Kazunori Kageyama; Komaki Hanada; Toshihiro Suda
Journal:  Regul Pept       Date:  2009-02-28
View more
  1 in total

Review 1.  Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Authors:  Carlos Manuel Zapata-Martín Del Campo; Martín Martínez-Rosas; Verónica Guarner-Lans
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.